Cancer Vaccine – A Review

Abstract

With the goal of enhancing the body's immune response against cancer cells, the creation of cancer vaccines represents a revolutionary change in oncology. Cancer vaccines, in contrast to conventional vaccinations, are intended to assist the immune system in identifying and getting rid of pre-existing malignancies. This article reviews the current landscape of cancer vaccine research, highlighting following categories: prophylactic vaccines and therapeutic immunizations. Recent advancements in personalized medicine and the integration of immune checkpoint inhibitors have further bolstered the efficacy of cancer vaccines. Challenges such as tumour heterogeneity, immune evasion, and the need for robust biomarkers remain critical areas for ongoing research. Overall, cancer vaccines hold significant promise for improving patient outcomes and integrating into broader cancer treatment regimens. Continued clinical trials and innovative strategies will be essential to realize their full potential in oncology.